Wait Times for Breast Surgical Operations, 2003–2011: A Report from the National Cancer Data Base

Annals of Surgical Oncology

Volumn 22, Issue 3, 2015, Pages 899-907

  Liederbach, Erik ^a   Sisco, Mark ^a   Wang, Chihsiung ^a   Pesce, Catherine ^a   Sharpe, Susan ^b   Winchester, David J ^a   Yao, Katharine ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMORBIDITY; DATA BASE; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAID; MEDICALLY UNINSURED; MEDICARE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; REOPERATION; SOCIAL STATUS; SOCIOECONOMICS; TIME; UNITED STATES; WAIT TIME; BREAST NEOPLASMS; EPIDEMIOLOGY; FACTUAL DATABASE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH INSURANCE; PATHOLOGY; PATIENT REFERRAL; PROGNOSIS; SEGMENTAL MASTECTOMY; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; REFERRAL AND CONSULTATION; TIME FACTORS; TIME-TO-TREATMENT; UNITED STATES;

EID: 84925490341     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4086-7     Document Type: Article

References (37)

1. Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen NM. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery. 2010;148:746–50.
2. Crivello ML, Ruth K, Sigurdson ER, et al. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population. Ann Surg Oncol. 2013;20:102–10.
3. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7.
4. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.
5. Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30:4485–92.
6. Colleoni M, Bonetti M, Coates AS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol. 2000;18:584–90.
7. Colleoni M, Gelber RD. Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better? J Clin Oncol. 2014;32:717–9.
8. Karlsson P, Cole BF, Colleoni M, et al. Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy. Int J Radiat Oncol Biol Phys. 2011;80:398–402.
9. Benk V, Joseph L, Fortin P, et al. Effect of delay in initiating radiotherapy for patients with early stage breast cancer. Clin Oncol (R Coll Radiol). 2004;16:6–11.
10. Balduzzi A, Leonardi MC, Cardillo A, et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev. 2010;36:443–50.
11. Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24:4888–94.
12. Gagliato Dde M, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014;32:735–44.
13. Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:240.
14. Rapoport Y, Kreitler S, Chaitchik S, Algor R, Weissler K. Psychosocial problems in head-and-neck cancer patients and their change with time since diagnosis. Ann Oncol. 1993;4:69–73.
15. Jones RV, Greenwood B. Breast cancer: causes of patients’ distress identified by qualitative analysis. Br J Gen Pract. 1994;44:370–1.
16. Gray RE, Fitch MI, Phillips C, Labrecque M, Klotz L. Presurgery experiences of prostate cancer patients and their spouses. Cancer Pract. 1999;7:130–5.
17. Desch CE, McNiff KK, Schneider EC, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008;26:3631–7.
18. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: The National Academies Press, 2001.
19. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–90.
20. Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27:4177–81.
21. Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the national cancer data base. J Am Coll Surg. 2014;219:19–28.
22. US Census. Statistical Groupings of States and Counties. 2010; http://www.census.gov/geo/reference/pdfs/GARM/Ch6GARM.pdf.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
24. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edn. New York, 2010.
25. International Classification of Disease for Oncology, 3rd edn. Geneva: World Health Organization; 2000.
26. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516–23.
27. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082–8.
28. Etzioni DA, Liu JH, Maggard MA, O’Connell JB, Ko CY. Workload projections for surgical oncology: will we need more surgeons? Ann Surg Oncol. 2003;10:1112–7.
29. Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanjian K, Lum SS. Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg. 2010;76:1119–22.
30. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166:2244–52.
31. Haggstrom DA, Carney TJ. Cancer care disparities: research regarding timeliness and potential coordination. Am J Manag Care. 2009;15:778–80.
32. Fedewa SA, Edge SB, Stewart AK, Halpern MT, Marlow NM, Ward EM. Race and ethnicity are associated with delays in breast cancer treatment (2003–2006). J Health Care Poor Underserved. 2011;22:128–41.
33. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99:313–21.
34. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467–75.
35. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551–6.
36. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553–64.
37. Vandergrift JL, Niland JC, Theriault RL, et al. Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst. 2013;105:104–12.